| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/23/2009 | US20090106853 Methods and materials using signaling probes |
| 04/23/2009 | US20090105454 Prophylactic/therapeutic agent for cancer |
| 04/23/2009 | US20090105453 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents |
| 04/23/2009 | US20090105452 Non-fluorescent quencher compounds and biomolecular assays |
| 04/23/2009 | US20090105281 Methods of treating inflammation |
| 04/23/2009 | US20090105272 Prodrugs of modulators of ABC transporters |
| 04/23/2009 | US20090105249 4-phenylsulfonamidopiperidines as calcium channel blockers |
| 04/23/2009 | US20090105240 Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same |
| 04/23/2009 | US20090105233 Serine-threonine protein kinase and parp modulators |
| 04/23/2009 | US20090105187 Methods of treating lentivirus infection |
| 04/23/2009 | US20090105184 Positron emission tomography probes for imaging immune activation and selected cancers |
| 04/23/2009 | US20090105177 Modulation of diacylglycerol acyltransferase 1 expression |
| 04/23/2009 | US20090105172 Stabilized Aptamers to PSMA and Their Use as Prostate Cancer Therapeutics |
| 04/23/2009 | US20090105170 Multiple Heat Shock Elements |
| 04/23/2009 | US20090105168 Use Of HDAC And/Or DNMT Inhibitors For Treatment Of Ischemic Injury |
| 04/23/2009 | US20090105167 Predicting responsiveness to cancer therapeutics |
| 04/23/2009 | US20090105136 NPY Y2 Agonist for Use as Therapeutic Agent for Disease Accompanied by Diarrhea |
| 04/23/2009 | US20090105092 Viral database methods |
| 04/23/2009 | US20090105088 Mutant bank |
| 04/23/2009 | US20090105086 Methods of selecting internalizing antibodies |
| 04/23/2009 | US20090105083 Ligand Screening and Discovery |
| 04/23/2009 | US20090105082 Non-invasive molecular colony methods, kits and apparatus |
| 04/23/2009 | US20090104703 Nucleic Acids Encoding Proteins Involved in Sensory Transduction |
| 04/23/2009 | US20090104693 a gene encoding the blood group Pk (Gb3) synthase, termed alpha 4Gal-T1, probes to the DNA encoding alpha 4Gal-T1, DNA constructs comprising DNA encoding alpha 4Gal-T1 |
| 04/23/2009 | US20090104690 Device for detecting an enzyme in a sample |
| 04/23/2009 | US20090104653 Bio-process model predictions from optical loss measurements |
| 04/23/2009 | US20090104652 Method and apparatus for viable and nonviable prokaryotic and eukaryotic cell quantitation |
| 04/23/2009 | US20090104651 Screening process for antibacterial agents |
| 04/23/2009 | US20090104650 Infectious diseases testing of menstrual fluid, endometrial/menstrual cells, amniotic fluid, umbilical cord blood or other samples |
| 04/23/2009 | US20090104649 Markers for preeclampsia |
| 04/23/2009 | US20090104648 Transgenic cell models comprised of osmosensing histidine kinase for use in identifying fungicides; polynucleotide encoding the kinase; drug screening |
| 04/23/2009 | US20090104647 Methods for selecting active agents for cancer treatment |
| 04/23/2009 | US20090104646 Generating preferential immunoglobulins in hypermutable cells for use as tools in antibody-dependent cellular cytotoxicity; immunotherapy; useful for generating antibody-producing cells with increased level of antibody production |
| 04/23/2009 | US20090104645 Vectors And Methods For Identifying Proteins Amenable To Crystallization |
| 04/23/2009 | US20090104644 Genetically modified cyclic-nucleotide controlled ion chan |
| 04/23/2009 | US20090104643 Bioluminescence-based sensor with centrifugal separation and enhanced light collection |
| 04/23/2009 | US20090104642 Novel ubiquitin ligases as therapeutic targets |
| 04/23/2009 | US20090104641 Providing blood specimen, exposing to cyclodextrin modified reagent, detecting electric current produced by reaction of hemoglobin and electron mediator under potentiostatic condition, calculate concentration of hemoglobin |
| 04/23/2009 | US20090104640 Method of Evaluating Biological Material and Bioreactor Therefor |
| 04/23/2009 | US20090104639 Biomarkers for motor neuron disease |
| 04/23/2009 | US20090104638 Methods for Building Atomic Models of Protein Molecules and Determining Drug Candidates Using MGST1 |
| 04/23/2009 | US20090104637 Method and Apparatus for Assaying Blood Clotting |
| 04/23/2009 | US20090104636 Quantitative analysis of a biological sample of unknown quantity |
| 04/23/2009 | US20090104635 Fluorescent Dry Test Strip Biosensor |
| 04/23/2009 | US20090104629 Use of biomarkers of alzheimer's disease for diagnostic tests and drug screening |
| 04/23/2009 | US20090104628 Method for quantifying phosphokinase activity on proteins |
| 04/23/2009 | US20090104621 Method for detecting a target nucleic acid sequence |
| 04/23/2009 | US20090104620 Simplified Method of Determining Predisposition to Scoliosis |
| 04/23/2009 | US20090104619 Human G-Protein Coupled Receptors |
| 04/23/2009 | US20090104618 Diagnosing high grade ductal carcinoma (mammary glands) in situ (DCIS) by determining the level of psoriasin gene expression in a sample |
| 04/23/2009 | US20090104617 Diagnostic and Prognostic Tests |
| 04/23/2009 | US20090104616 Primer set for amplifying sult1a1 gene, reagent for amplifying sult1a1 gene containing the same, and the uses thereof |
| 04/23/2009 | US20090104615 Phenotype prediction |
| 04/23/2009 | US20090104614 Quantitative molecular probes |
| 04/23/2009 | US20090104613 Methods and compositions relating to multiplexed genomic gain and loss assays |
| 04/23/2009 | US20090104612 Detection of blood group genes |
| 04/23/2009 | US20090104611 Methods of whole genome analysis |
| 04/23/2009 | US20090104610 Real-Time Multiplex Detection of Three Bacterial Species Responsible for Sexually Transmitted Diseases |
| 04/23/2009 | US20090104609 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| 04/23/2009 | US20090104608 EUBACTERIAL tmRNA SEQUENCES AND USES THEREOF |
| 04/23/2009 | US20090104607 EUBACTERIAL tmRNA SEQUENCES AND USES THEREOF |
| 04/23/2009 | US20090104606 Late gestation lung genes, fragments and uses thereof |
| 04/23/2009 | US20090104605 Diagnosis of sepsis |
| 04/23/2009 | US20090104604 Sperm-specific cation channel, catsper2, and uses therefor |
| 04/23/2009 | US20090104603 Tissue Carbohydrate Compositions and Analysis Thereof |
| 04/23/2009 | US20090104602 Diagnosis of Tuberculosis |
| 04/23/2009 | US20090104601 Genetic diagnosis using multiple sequence variant analysis |
| 04/23/2009 | US20090104600 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
| 04/23/2009 | US20090104599 Genetic variant of the annexin a5 gene |
| 04/23/2009 | US20090104598 Dopamine D2 receptor gene variants |
| 04/23/2009 | US20090104597 Advanced cervical cell screening methods |
| 04/23/2009 | US20090104596 Noninvasive Measurement and Identification of Biomarkers in Disease State |
| 04/23/2009 | US20090104595 Methods for determining the sensitivity or resistance of retrovirus isolates to therapeutic retroviral treatments based on viral protease inhibitors and diagnostic kits |
| 04/23/2009 | US20090104279 Use of pak inhibitor for the treatment of a joint disease |
| 04/23/2009 | US20090104230 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/23/2009 | US20090104221 Rapid generation of t cell-independent antibody responses to t cell-dependent antigens |
| 04/23/2009 | US20090104209 Methods of reducing a viral infection and kits therefore |
| 04/23/2009 | US20090104207 Hepatitis C Virus Neutralizing Antibodies |
| 04/23/2009 | US20090104203 Compositions and Methods for Regulating Osteoclast Differentiation, Activation and Bone Resorption |
| 04/23/2009 | US20090104199 Breast Cancer Resistance Protein (BCRP) And The DNA Which Encodes It |
| 04/23/2009 | US20090104198 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 04/23/2009 | US20090104197 vWFA and/or ANT_IG Domain Containing Proteins |
| 04/23/2009 | US20090104193 SEMA4D in Cancer Diagnosis, Detection and Treatment |
| 04/23/2009 | US20090104189 Neutrokine-alpha and neutrokine-alpha splice variant |
| 04/23/2009 | US20090104185 Methods and Compositions for Mycoplasma Toxins |
| 04/23/2009 | US20090104182 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/23/2009 | US20090104178 Chemokine binding activity of viral tnf receptors and related proteins |
| 04/23/2009 | US20090104160 Mobilization of Stem Cells After Trauma and Methods Therefor |
| 04/23/2009 | US20090104147 Sialoadhesin-Related Compositions and Methods |
| 04/23/2009 | US20090104122 DETECTION OF MEMBRANE ANDROGEN RECEPTOR (mAR) AGENTS |
| 04/23/2009 | US20090104121 Multi-subunit biological complexes for treatment of plaque-associated diseases |
| 04/23/2009 | US20090101523 System and Methods for Determination of Analyte Concentration Using Time Resolved Amperometry |
| 04/23/2009 | US20090101506 Method, specific primers and kit for the detection of neisseria meningitidis |
| 04/23/2009 | US20090101498 Glucose sensors and methods of manufacture thereof |
| 04/23/2009 | CA2740882A1 Use of ps20/wfdc1 and interferons to diagnose, monitor and treat viral diseases |
| 04/23/2009 | CA2706288A1 Method for administering anticoagulation therapy |
| 04/23/2009 | CA2703120A1 Detection of blood group genes |
| 04/23/2009 | CA2703026A1 Prognostic molecular markers for et-743 treatment |
| 04/23/2009 | CA2702969A1 Electrochemical assay for the detection of enzymes |
| 04/23/2009 | CA2702686A1 Translocation and mutant ros kinase in human non-small cell lung carcinoma |